1. Ambrosch, F./Fedson, D.S. (1999). Influenza vaccination in 29 Countries: An Update to 1997. Pharmacoeconomics, 16 Suppl 2, 47–54
2. American Academy of Pediatrics. (2000). Red Book, 4th Italian Edition, CIS Milan.
3. Ansaldi, F./D’Agaro, P./de Florentiis, D./Crovari, P./Gasparini, R./Donatelli, I./Puzzelli, S./Gregory, V./Bennett, M./Lin, Y./Hay, A./Campello, C. (in press). Molecular characterisation of influenza viruses circulating in Northern Italy during the 2001-2002 epidemic season. J Med Virol.
4. Arulanandam, B.P./O’Tool, M./Metzger, D.W. (1999). Intranasal interleukin 12 is a powerful adjuvant for protective mucosal immunity. J Infect Dis, 180, 940–949.
5. Belshe, R.B./Gruber, W.C./Mendelman, P.M. et al. (2000). Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus against a variant (A/Sidney) not contained in the vaccine. J Pediatrics, 136, 168–175.